Form 8-K for EDGAR FILINGNET INC
--------------------------------------------------------------------------------
20-Mar-2008
Change in Directors or Principal Officers
Item 5.02 Appointment of Director and Principal Officer. On March 20, 2008, the Board of Directors unanimously approved and appointed Mr Timothy E. Taylor to the Board of Directors of CCAJ and unanimously approved and appointed Mr. Jeff Radcliffe as its Chief Operating Officer.
Mr. Taylor is the co-founder and VP of Engineering of Endius, Inc. a Boston, MA based surgical device company. The world's largest orthopedic company Zimmer acquired Endius in March, 2007 in a cash transaction estimated by Wachovia at $75m-$125m. Endius is one of the fastest growing spinal device and implant companies in the U.S. and has raised more venture capital money in 2003 and 2004 than any other medical device company. Investors include Morgan Stanley Ventures, The Carlyle Group, Polaris Ventures, New England Venture Capital, Hickory Venture Capital and Hillman Medical. After hiring a seasoned CEO, Tim resigned from Endius in 2000 to move back south and become a venture capitalist.
IUniverse published Tim's entrepreneurial, non-fiction book Launch Fever in 2003. He has an engineering degree from Mississippi State University and a Masters Degree in Business from Florida Institute of Technology and 24 issued patents related to medical devices and material coatings.
Mr. Radcliffe has been a founder of several high-tech start-ups. Most recently Jeff was COO of Reflective, a software security startup. Prior to that, he was COO/CTOof logistics software provider 180 Commerce. He also served as CIO and General Manager of the Atlantaoffice for strategic Internet services firm iXL. During his three-year tenure at iXL, Jeff's operational expertise helped grow the company from 50 to 2,800 people generating over $200 million in revenue including a successful IPO and secondary offering. Jeff was also founder and CEO of Ratiofor ten years, a new productdesign and development companyfocused on medical products. Ratio's innovative prototypes formed the basis for several highly technical products used in medical research, electronics and engineering testing.
Mr. Radcliffewill assume the responsibilities of overseeing the forensic accounting and audits as well as assisting the Board on building out the management team and evaluating business alternatives. |